Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: HER-2/neu peptide vaccine
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)